Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ICON Expands Asia Pacific Footprint With New Focus On Southeast Asian Countries

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Driven by increasing interest for drug development programs in Southeast Asia, Ireland-based ICON is expanding its Asia Pacific footprint in the Philippines

You may also be interested in...

Boehringer Ingelheim And Ecron Acunova Think Regionally For Clinical Trials – Bangalore Bio

Boehringer sees advantages to a long-term, and expansive CRO partnership instead of carving up markets in Asia.

ICON Goes Local As China CRO Market Heats Up

Acquisition of BeijingWits will boost ICON’s clinical trial capabilities in China and the Asia Pacific region.

ICON Opens New Asian Offices To Keep Pace With Growing Demand For More Trials In Emerging Markets

BEIJING - Ireland-headquartered global contract research organization ICON is expanding its presence in the Asia Pacific region due to the growing attractiveness of conducting clinical trials in the region

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts